SciDev Bilan de santé

Santé financière contrôle des critères 6/6

SciDev possède un total de capitaux propres de A$50.2M et une dette totale de A$0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont A$72.0M et de A$21.8M. L'EBIT de SciDev est A$4.8M ce qui fait que son ratio de couverture des intérêts 7.3. Elle dispose de liquidités et de placements à court terme de A$9.4M.

Informations clés

Ratio d'endettement

AU$0

Dette

Ratio de couverture des intérêts	7.3x
Argent liquide	AU$9.43m
Fonds propres	AU$50.24m
Total du passif	AU$21.78m
Total des actifs	AU$72.01m

Mises à jour récentes de la santé financière

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Nov 13

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

Sep 30

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Dec 22

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

Nov 16

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Oct 25

When Should You Buy SciDev Limited (ASX:SDV)?

May 18

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

Mar 06

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Feb 28

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

Oct 28

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Jun 09

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

Feb 02

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Sep 07

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

Feb 01

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de SDV ( A$30.0M ) dépassent ses passifs à court terme ( A$20.1M ).

Passif à long terme: Les actifs à court terme de SDV ( A$30.0M ) dépassent ses passifs à long terme ( A$1.6M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: SDV est sans dette.

Réduire la dette: SDV n'avait aucune dette il y a 5 ans.

Couverture de la dette: SDV n'a pas de dette, elle n'a donc pas besoin d'être couverte par le flux de trésorerie opérationnel.

Couverture des intérêts: SDV n'a aucune dette, par conséquent la couverture des paiements d'intérêts n'est pas un problème.

SciDev Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

SciDev Limited Ordinary Shares to Be Deleted from Other OTC

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

SciDev Limited, Annual General Meeting, Nov 21, 2024

Full year 2024 earnings: EPS misses analyst expectations

The Return Trends At SciDev (ASX:SDV) Look Promising

SciDev Limited (ASX:SDV) Surges 73% Yet Its Low P/S Is No Reason For Excitement

Price target increased by 29% to AU$0.54

First half 2024 earnings released: EPS: AU$0 (vs AU$0 in 1H 2023)

SciDev (ASX:SDV) Is Looking To Continue Growing Its Returns On Capital

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

SciDev Limited, Annual General Meeting, Nov 21, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.4% to AU$0.50

When Should You Buy SciDev Limited (ASX:SDV)?

Consensus EPS estimates fall by 29%

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

First half 2023 earnings released: EPS: AU$0 (vs AU$0.014 loss in 1H 2022)

Independent & Non-Executive Director recently bought AU$80k worth of stock

Price target increased to AU$0.52

SciDev Ltd Appoints Seán Halpin as Chief Executive Officer

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

SciDev Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.023 profit in FY 2021)

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Price target decreased to AU$0.75

First half 2022 earnings: EPS exceeds analyst expectations

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

SciDev Limited Ordinary Shares to Be Deleted from Other OTC

Interim Chief Financial Officer Geoff Stephenson has left the company

Price target decreased to AU$1.01

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.007 loss in FY 2020)

High number of new and inexperienced directors

Non-Executive Chairman Trevor Jones has left the company

SciDev Limited (ASX:SDV) completed the acquisition of Business of Haldon Industries.

SciDev Limited Maxiflox Contract with Eramet Subsidiary SLN

New 90-day low: AU$0.65

First half 2021 earnings released: EPS AU$0.003 (vs AU$0.002 loss in 1H 2020)

SciDev Limited Announces Executive Changes

Revenue beats expectations

SciDev Limited Names Dan O'Toole BEng to the Board as an Independent, Non-Executive Director

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

New 90-day low: AU$0.70

SciDev Limited Provides an Update on the Increased Activity Levels Within the US Oil and Gas Sector

MD, CEO & Executive Director exercised options and sold AU$517k worth of stock

New 90-day high: AU$0.90

Non-Executive Chairman recently bought AU$62k worth of stock

Non-Executive Chairman recently bought AU$62k worth of stock

Earnings released

New 90-day high - AU$0.88

SciDev Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines